Abstract
TRANSDUCTION of a mitogenic signal from the cell membrane to the nucleus involves the adapter proteins SHC and Grb2, which mediate activation of the Ras/mitogen-activated protein (MAP) kinase pathway1–5. In contrast to receptor tyrosine kinases (RTKs), the signalling steps leading to Ras/MAP kinase activation by G-protein-coupled receptors (GPCRs) are still poorly characterized but appear to include βγ subunits of heterotrimeric G-proteins and as-yet unidentified tyrosine kinases6–8. We report here that the epidermal growth factor receptor (EGFR) and the neu oncoprotein become rapidly tyrosine-phosphorylated upon stimulation of Rat-1 cells with the GPCR agonists endothelin-1, lysophosphatic acid and thrombin, suggesting that there is an intracellular mechanism for transactivation. Specific inhibition of EGFR function by either the selective tyrphostin AG1478 or a dominant-negative EGFR mutant suppressed MAP kinase activation and strongly inhibited induction of fos gene expression and DNA synthesis. Our results demonstrate a role for RTKs as downstream mediators in GPCR mitogenic signalling and suggest a ligand-independent mechanism of RTK activation through intracellular signal crosstalk.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ullrich, A. & Schlessinger, J. Cell 61, 203–212 (1990).
van der Geer, P. & Hunter, T. A. Rev. Cell Biol. 10, 251–337 (1994).
Burgering, B. M. T. & Bos, J. L. Trends biochem. Sci. 20, 18–22 (1995).
Egan, S. E. et al. Nature 363, 45–51 (1993).
van Biesen, T. et al. Nature 376, 781–784 (1995).
van Corven, E. J., Hordijk, P. L., Medema, R. H., Bos, J. L. & Moolenaar, W. H. Proc. natn. Acad. Sci. U.S.A. 90, 1257–1261 (1993).
Faure, M., Voyno-Yasenetskaya, T. A. & Bourne, H. J. biol. Chem. 269, 7851–7854 (1994).
Crespo, P., Xu, N., Simonds, W. F. & Gutkind, J. A. Nature 369, 418–420 (1994).
Muldoon, L. L., Pribnow, D., Rodland, K. D. & Magun, B. E. Cell Reg. 1, 379–390 (1990).
van Corven, E. J., Groenink, A., Jalink, K., Eichholtz, T. & Moolenaar, W. H. Cell 59, 45–54 (1989).
Gupta, S. K., Gallego, C., Johnson, G. L. & Heasley, L. E. J. biol. Chem. 267, 7987–7990 (1992).
Ambar, I. & Sokolovsky, M. Eur. J. Pharmac. 245, 31–41 (1993).
Vu, T.-K. H., Hung, D. T., Wheaton, V. I. & Coughlin, S. R. Cell 64, 1057–1068 (1991).
Redemann, N., Holzmann, B., von Rüden, T., Wagner, E. F., Schlessinger, J. & Ullrich, A. Molec. cell. Biol. 12, 491–498 (1992).
Bargmann, C. I., Hung, M.-C. & Weinberg, R. A. Nature 319, 226–229 (1986).
Kashles, O., Yarden, Y., Fischer, R., Ullrich, A. & Schlessinger, J. J. Molec. cell. Biol. 11, 1454–1463 (1991).
Levitzki, A. & Gazit, A. Science 267, 1782–1788 (1995).
Zachary, I., Sinnett-Smith, J., Turner, C. E. & Rozengurt, E. J. biol. Chem. 268, 22060–22065 (1993).
Ohmichi, M. et al. J. biol. Chem. 269, 3783–3788 (1994).
Cazaubon, S. M. et al. J. biol. Chem. 269, 24805–24809 (1994).
Lev, S. et al. Nature 276, 737–745 (1995).
Hill, C. S., Wynne, J. & Treisman, R. Cell 81, 1159–1170 (1995).
Cano, E., Hazzalin, C. A. & Mahadevan, L. C. Molec. cell. Biol. 14, 7352–7362 (1994).
Coso, O. A. et al. J. biol. Chem. 270, 5620–5624 (1995).
Linseman, D. A., Benjamin, C. W. & Jones, D. A. J. biol. Chem. 270, 12563–12568 (1995).
Marrero, M. B., Paxton, W. G., Duff, J. L., Berk, B. C. & Bernstein, K. E., J. biol. Chem. 269, 10935–10939 (1994).
Rivard, N., McKenzie, F, R., Brondello, J.-M. & Pouysségur, J. J. biol. Chem. 270, 11017–11024 (1995).
Kumagai, N., Morii, N., Fujisawa, K., Nemoto, Y. & Narumiya, A. J. biol. Chem. 268, 24535–24538 (1993).
Sachsenmeier, C. et al. Cell 78, 963–972 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Daub, H., Ulrich Weiss, F., Wallasch, C. et al. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379, 557–560 (1996). https://doi.org/10.1038/379557a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/379557a0
This article is cited by
-
The G protein-coupled oestrogen receptor GPER in health and disease: an update
Nature Reviews Endocrinology (2023)
-
Interruption of the long non-coding RNA HOTAIR signaling axis ameliorates chemotherapy-induced cachexia in bladder cancer
Journal of Biomedical Science (2022)
-
Diversification of PAR signaling through receptor crosstalk
Cellular & Molecular Biology Letters (2022)
-
The LRP1/CD91 ligands, tissue-type plasminogen activator, α2-macroglobulin, and soluble cellular prion protein have distinct co-receptor requirements for activation of cell-signaling
Scientific Reports (2022)
-
GPCR-mediated EGFR transactivation ameliorates skin toxicities induced by afatinib
Acta Pharmacologica Sinica (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.